American Medical Systems Announces Extension to July 19 of Cash Tender Offer for Laserscope Acquisition
2006年7月12日 - 2:23AM
ビジネスワイヤ(英語)
American Medical Systems Holdings, Inc. (NASDAQ:AMMD), the global
leader in providing pelvic health solutions to urologists and
gynecologists, announced today that it has extended the expiration
date of its cash tender offer for shares of Laserscope
(NASDAQ:LSCP). As previously announced and unanimously approved by
the Boards of Directors of both companies, the tender offer is to
acquire all of the outstanding shares of Laserscope at a purchase
price of $31.00 net per share, pursuant to an Agreement and Plan of
Merger, dated June 3, 2006. The Laserscope Board of Directors has
recommended that Laserscope shareholders tender their shares into
the offer. Through the close of business on July 10, 2006, a total
of 3,903,637 Laserscope shares had been tendered, constituting
approximately 17.4 percent of the shares outstanding. The
expiration for the tender offer has been extended to 12:00
midnight, central time, on Wednesday, July 19, 2006, unless further
extended. As initially announced, the tender offer was scheduled to
expire at 12:00 midnight, central time, on Wednesday, July 12,
2006. Martin J. Emerson, President and Chief Executive Officer,
commented, "We have extended the tender offer period to allow for
additional time to reach our minimum condition of 90 percent of
Laserscope shares being tendered. In addition, while we have
successfully completed our offering of convertible senior
subordinated notes, we have an aggressive schedule to complete the
senior secured loan facility to fund a portion of the purchase
price. We have completed the syndication and negotiation of loan
documentation for the senior secured loan facility. The tender
extension will allow completion of the various procedural steps
necessary to close the facility." About American Medical Systems
American Medical Systems, headquartered in Minnetonka, Minnesota is
a diversified supplier of medical devices and procedures to cure
erectile dysfunction, benign prostatic hyperplasia, incontinence,
menorrhagia, prolapse and other pelvic disorders in men and women.
These disorders can significantly diminish one's quality of life
and profoundly affect social relationships. In recent years, the
number of people seeking treatment has increased markedly as a
result of longer lives, higher quality-of-life expectations and
greater awareness of new treatment alternatives. American Medical
Systems' products reduce or eliminate the incapacitating effects of
these diseases, often through minimally invasive therapies. The
Company's products were used to provide approximately 170,000
patient cures in 56 countries during 2005. More information about
AMS can be found on its website at www.AmericanMedicalSystems.com.
About Laserscope Laserscope designs, manufactures, sells and
services an advanced line of minimally invasive medical products
worldwide including medical laser systems and related energy
delivery devices for the office, outpatient surgical center and
hospital markets. More information about Laserscope can be found on
its website at www.Laserscope.com. Additional Information This
announcement is neither an offer to purchase nor a solicitation of
an offer to sell shares of Laserscope. American Medical Systems
Holdings, Inc. has filed a tender offer statement with the
Securities and Exchange Commission (SEC) and Laserscope has filed a
solicitation/recommendation statement with respect to the offer.
Laserscope shareholders are advised to read the tender offer
statement regarding the acquisition of Laserscope referenced in
this news release, and the related solicitation/recommendation
statement. The tender offer statement and the
solicitation/recommendation statement contain important information
that should be read carefully before any decision is made with
respect to the offer. These documents will be made available to all
shareholders of Laserscope at no expense to them. These documents
will also be available at no charge on the SEC's web site at
www.sec.gov. Shareholders may also obtain copies of these documents
without charge by requesting them from Laserscope, Inc. in writing
at 3070 Orchard Drive, San Jose, CA 95134, or by phone at
408-943-0636.
Laserscope (NASDAQ:LSCP)
過去 株価チャート
から 9 2024 まで 10 2024
Laserscope (NASDAQ:LSCP)
過去 株価チャート
から 10 2023 まで 10 2024
Real-Time news about Laserscope (MM) (ナスダック市場): 0 recent articles
その他のAmerican Medical Systemsニュース記事